MGUS Risk of Progression Per Year

Estimate annual and 20-year risk of MGUS progressing to myeloma or related disorder using the Mayo risk stratification model based on M-protein size, type, and FLC ratio.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate annual and 20-year risk of MGUS progressing to myeloma or related disorder using the Mayo risk stratification model based on M-protein size, type, and FLC ratio

Each component has a specific meaning:

  • Mayo risk stratification model based on M-protein size — The mayo risk stratification model based on m-protein size recorded for the scenario being assessed.
  • Type — The type recorded for the scenario being assessed.
  • FLC ratio — The flc ratio recorded for the scenario being assessed.

Note: Interpret the mgus progression risk result against the thresholds and context described above.

How to Use

Enter the Mayo risk stratification model based on M-protein size, type, FLC ratio for the scenario you are assessing. Estimate annual and 20-year risk of MGUS progressing to myeloma or related disorder using the Mayo risk stratification model based on M-protein size, type, and FLC ratio. Use the mgus progression risk result to inform your calculation.

Related Calculators

Smoldering Myeloma

Medical Long-tail

Free Light Chain Ratio

Medical Long-tail

Frequently Asked Questions